USP22 and hepatocellular carcinoma: In addition, according to publicly available data (n = 340) in The Human Protein Atlas (https://www.proteinatlas.org/), high expression of USP22 was significantly associated with poor clinical outcome in HCC patients (Supplementary Fig. S1D).